WaveMan · Form 4
Baker Bros. Advisors LP insider trades
> Search tickers & screens ⌘K
LIVE

Baker Bros. Advisors LP insider trades

Baker Bros. Advisors LP has filed 36 Form 4s with the SEC that we hold, for Incyte Corp (INCY) (Director, 10% owner), Kodiak Sciences Inc. (KOD) (Director, 10% owner), Entrada Therapeutics, Inc. (TRDA) (10% owner) and IGMS (Reporting owner), among 16 companies in all. Across all of them we count 146 purchases worth $210.3M and 4 sales worth $317.9M reported on Form 4. In the last 12 months: 82 purchases ($157.0M) and 4 sales ($317.9M). The largest single trade was a sale of 2,838,632 shares of Celcuity Inc. worth $291.0M, dated 2026-07-14. The first filing on our record is dated 2021-10-01 and the latest 2026-10-02.

Incyte Corp (INCY)

Director, 10% owner · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kodiak Sciences Inc. (KOD)

Director, 10% owner · 6 filings · 95 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-30P, purchase reported on Form 486,932$8.3M2021-10-01
2022-01-27P, purchase reported on Form 454,024$2.8M2022-01-31
2022-01-27P, purchase reported on Form 486,479$4.5M2022-01-31
2022-01-27P, purchase reported on Form 4117,291$6.1M2022-01-31
2022-01-27P, purchase reported on Form 44,465$230.7K2022-01-31
2022-01-28P, purchase reported on Form 411,526$594.9K2022-01-31
2022-01-28P, purchase reported on Form 41,851$92.0K2022-01-31
2022-01-28P, purchase reported on Form 422,395$1.1M2022-01-31
2022-01-28P, purchase reported on Form 41,414$71.5K2022-01-31
2022-01-28P, purchase reported on Form 417,119$865.5K2022-01-31
2022-01-28P, purchase reported on Form 4953$49.2K2022-01-31
2022-01-31P, purchase reported on Form 42,307$132.0K2022-01-31
2022-01-31P, purchase reported on Form 427,841$1.6M2022-01-31
2026-09-28P, purchase reported on Form 4856$52.4K2026-09-30
2026-09-28P, purchase reported on Form 414,344$878.0K2026-09-30
2026-09-28P, purchase reported on Form 42,666$164.3K2026-09-30
2026-09-28P, purchase reported on Form 444,690$2.8M2026-09-30
2026-09-28P, purchase reported on Form 4243$15.3K2026-09-30
2026-09-28P, purchase reported on Form 44,067$256.1K2026-09-30
2026-09-28P, purchase reported on Form 4479$30.9K2026-09-30
2026-09-28P, purchase reported on Form 48,021$516.8K2026-09-30
2026-09-28P, purchase reported on Form 4321$21.5K2026-09-30
2026-09-28P, purchase reported on Form 45,382$361.1K2026-09-30
2026-09-28P, purchase reported on Form 4154$10.5K2026-09-30
2026-09-28P, purchase reported on Form 42,585$176.7K2026-09-30
2026-09-28P, purchase reported on Form 42,331$160.7K2026-09-30
2026-09-28P, purchase reported on Form 439,066$2.7M2026-09-30
2026-09-28P, purchase reported on Form 41,056$75.5K2026-09-30
2026-09-28P, purchase reported on Form 417,698$1.3M2026-09-30
2026-09-28P, purchase reported on Form 416,641$1.2M2026-09-30
2026-09-28P, purchase reported on Form 4278,978$20.2M2026-09-30
2026-09-28P, purchase reported on Form 44,696$343.2K2026-09-30
2026-09-28P, purchase reported on Form 478,726$5.8M2026-09-30
2026-09-28P, purchase reported on Form 44,577$338.6K2026-09-30
2026-09-28P, purchase reported on Form 476,723$5.7M2026-09-30
2026-09-28P, purchase reported on Form 41,924$145.3K2026-09-30
2026-09-28P, purchase reported on Form 432,261$2.4M2026-09-30
2026-09-28P, purchase reported on Form 43,681$281.0K2026-09-30
2026-09-28P, purchase reported on Form 461,700$4.7M2026-09-30
2026-09-28P, purchase reported on Form 42,884$223.3K2026-09-30
2026-09-28P, purchase reported on Form 448,350$3.7M2026-09-30
2026-09-28P, purchase reported on Form 42,969$233.3K2026-09-30
2026-09-28P, purchase reported on Form 449,771$3.9M2026-09-30
2026-09-28P, purchase reported on Form 4534$42.4K2026-09-30
2026-09-28P, purchase reported on Form 48,956$711.1K2026-09-30
2026-09-28P, purchase reported on Form 417$1.4K2026-09-30
2026-09-28P, purchase reported on Form 4283$22.5K2026-09-30
2026-09-28P, purchase reported on Form 4884$70.5K2026-09-30
2026-09-28P, purchase reported on Form 414,827$1.2M2026-09-30
2026-09-28P, purchase reported on Form 4404$32.4K2026-09-30
2026-09-28P, purchase reported on Form 46,783$544.2K2026-09-30
2026-09-28P, purchase reported on Form 461$4.9K2026-09-30
2026-09-28P, purchase reported on Form 41,027$82.7K2026-09-30
2026-09-28P, purchase reported on Form 41,024$83.0K2026-09-30
2026-09-28P, purchase reported on Form 417,159$1.4M2026-09-30
2026-09-28P, purchase reported on Form 4338$27.4K2026-09-30
2026-09-28P, purchase reported on Form 45,654$459.1K2026-09-30
2026-09-28P, purchase reported on Form 41,044$84.9K2026-09-30
2026-09-28P, purchase reported on Form 417,490$1.4M2026-09-30
2026-09-28P, purchase reported on Form 41,672$136.8K2026-09-30
2026-09-28P, purchase reported on Form 428,028$2.3M2026-09-30
2026-09-28P, purchase reported on Form 439$3.2K2026-09-30
2026-09-28P, purchase reported on Form 4651$53.3K2026-09-30
2026-09-28P, purchase reported on Form 4101$8.4K2026-09-30
2026-09-28P, purchase reported on Form 41,699$140.5K2026-09-30
2026-09-28P, purchase reported on Form 41,167$97.0K2026-09-30
2026-09-28P, purchase reported on Form 419,554$1.6M2026-09-30
2026-09-28P, purchase reported on Form 47,390$620.4K2026-09-30
2026-09-28P, purchase reported on Form 4123,888$10.4M2026-09-30
2026-09-28P, purchase reported on Form 46,553$556.1K2026-09-30
2026-09-28P, purchase reported on Form 4109,842$9.3M2026-09-30
2026-09-28P, purchase reported on Form 42,322$199.6K2026-09-30
2026-09-28P, purchase reported on Form 438,932$3.3M2026-09-30
2026-09-28P, purchase reported on Form 4186$16.1K2026-09-30
2026-09-28P, purchase reported on Form 43,114$270.1K2026-09-30
2026-09-28P, purchase reported on Form 4957$83.1K2026-09-30
2026-09-28P, purchase reported on Form 416,036$1.4M2026-09-30
2026-09-28P, purchase reported on Form 43,790$329.5K2026-09-30
2026-09-28P, purchase reported on Form 463,539$5.5M2026-09-30
2026-09-28P, purchase reported on Form 44,485$392.5K2026-09-30
2026-09-28P, purchase reported on Form 475,176$6.6M2026-09-30
2026-09-28P, purchase reported on Form 45,880$520.8K2026-09-30
2026-09-28P, purchase reported on Form 498,561$8.7M2026-09-30
2026-09-28P, purchase reported on Form 46,428$569.8K2026-09-30
2026-09-28P, purchase reported on Form 4107,772$9.6M2026-09-30
2026-09-28P, purchase reported on Form 44,932$441.9K2026-09-30
2026-09-28P, purchase reported on Form 482,673$7.4M2026-09-30
2026-09-28P, purchase reported on Form 411,729$1.1M2026-09-30
2026-09-28P, purchase reported on Form 4196,608$17.7M2026-09-30
2026-09-29P, purchase reported on Form 4619$52.1K2026-09-30
2026-09-29P, purchase reported on Form 410,381$874.5K2026-09-30
2026-09-29P, purchase reported on Form 41,195$102.1K2026-09-30
2026-09-29P, purchase reported on Form 420,031$1.7M2026-09-30
2026-09-29P, purchase reported on Form 484$7.2K2026-09-30
2026-09-29P, purchase reported on Form 41,416$121.6K2026-09-30

Entrada Therapeutics, Inc. (TRDA)

10% owner · 3 filings · 18 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-16P, purchase reported on Form 42,063$12.0K2022-05-18
2022-05-16P, purchase reported on Form 416,937$98.7K2022-05-18
2022-05-17P, purchase reported on Form 42,010$12.3K2022-05-18
2022-05-17P, purchase reported on Form 416,501$101.2K2022-05-18
2022-05-18P, purchase reported on Form 484$4972022-05-18
2022-05-18P, purchase reported on Form 4692$4.1K2022-05-18
2022-05-18P, purchase reported on Form 430,003$180.0K2022-05-18
2022-05-18P, purchase reported on Form 43,654$21.9K2022-05-18
2022-05-20P, purchase reported on Form 47,248$42.3K2022-05-24
2022-05-20P, purchase reported on Form 4946$5.5K2022-05-24
2022-05-20P, purchase reported on Form 47,772$45.4K2022-05-24
2022-05-20P, purchase reported on Form 4883$5.2K2022-05-24
2022-05-23P, purchase reported on Form 47,010$42.0K2022-05-24
2022-05-23P, purchase reported on Form 4827$5.0K2022-05-24
2022-05-24P, purchase reported on Form 41,521$9.0K2022-05-24
2022-05-24P, purchase reported on Form 42,334$13.4K2022-05-24
2022-05-24P, purchase reported on Form 419,789$113.6K2022-05-24
2022-05-24P, purchase reported on Form 4179$1.1K2022-05-24

IGMS

Reporting owner · 3 filings · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-03-26P, purchase reported on Form 422,344$184.6K2024-03-28
2024-03-26P, purchase reported on Form 4247,656$2.0M2024-03-28
2024-03-27P, purchase reported on Form 48,439$78.2K2024-03-28
2024-03-27P, purchase reported on Form 4761$7.1K2024-03-28
2024-03-27P, purchase reported on Form 41,543$14.2K2024-03-28
2024-03-27P, purchase reported on Form 417,101$157.7K2024-03-28
2024-03-28P, purchase reported on Form 489,407$860.1K2024-03-28
2024-03-28P, purchase reported on Form 48,066$77.6K2024-03-28

Acadia Pharmaceuticals INC (ACAD)

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

BeOne Medicines Ltd. (ONC)

Director · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-05-22S, sale reported on Form 42,743$65.4K2026-05-27
2026-05-22S, sale reported on Form 42,756$65.6K2026-05-27

Bicycle Therapeutics PLC (BCYC)

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kymera Therapeutics, Inc. (KYMR)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Madrigal Pharmaceuticals, INC. (MDGL)

Director · 2 filings · 24 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-12-13P, purchase reported on Form 42,373$518.4K2023-12-14
2023-12-13P, purchase reported on Form 429,738$6.5M2023-12-14
2023-12-13P, purchase reported on Form 4360$79.2K2023-12-14
2023-12-13P, purchase reported on Form 44,518$993.4K2023-12-14
2023-12-13P, purchase reported on Form 4361$80.1K2023-12-14
2023-12-13P, purchase reported on Form 44,532$1.0M2023-12-14
2023-12-13P, purchase reported on Form 4738$164.3K2023-12-14
2023-12-13P, purchase reported on Form 49,262$2.1M2023-12-14
2023-12-13P, purchase reported on Form 429$6.5K2023-12-14
2023-12-13P, purchase reported on Form 4363$81.3K2023-12-14
2023-12-13P, purchase reported on Form 4446$100.3K2023-12-14
2023-12-13P, purchase reported on Form 45,594$1.3M2023-12-14
2023-12-13P, purchase reported on Form 4818$177.3K2023-12-14
2023-12-13P, purchase reported on Form 410,264$2.2M2023-12-14
2023-12-13P, purchase reported on Form 4869$189.0K2023-12-14
2023-12-13P, purchase reported on Form 410,894$2.4M2023-12-14
2023-12-14P, purchase reported on Form 4107$24.3K2023-12-14
2023-12-14P, purchase reported on Form 41,343$304.8K2023-12-14
2023-12-14P, purchase reported on Form 4925$210.8K2023-12-14
2023-12-14P, purchase reported on Form 411,602$2.6M2023-12-14
2023-12-14P, purchase reported on Form 4176$40.3K2023-12-14
2023-12-14P, purchase reported on Form 42,204$504.3K2023-12-14
2023-12-14P, purchase reported on Form 4316$72.6K2023-12-14
2023-12-14P, purchase reported on Form 43,960$910.2K2023-12-14

TScan Therapeutics, Inc. (TCRX)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Celcuity Inc. (CELC)

Reporting owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-07-14S, sale reported on Form 4261,368$26.8M2026-07-16
2026-07-14S, sale reported on Form 42,838,632$291.0M2026-07-16

Denali Therapeutics Inc. (DNLI)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Neurogene Inc. (NGNE)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Replimune Group, Inc. (REPL)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

SGEN

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

TLIS

Director, 10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-11-18P, purchase reported on Form 450,000$218.5K2021-11-19
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1263508) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms